Securities Registration Statement (simplified Form) (s-3/a)
July 06 2021 - 4:51PM
Edgar (US Regulatory)
As
filed with the U.S. Securities and Exchange Commission on July 6, 2021
Registration
No. 333-257645
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
PRE-EFFECTIVE
AMENDMENT NO. 1
TO
FORM
S-3
REGISTRATION
STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
Aditx
Therapeutics, Inc.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
82-3204328
|
(State
or other jurisdiction of
incorporation or organization)
|
|
(I.R.S.
Employer
Identification No.)
|
2569
Wyandotte Street
Suite
101
Mountain
View, CA 94043
(650)
870-1200
(Address,
including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Amro
Albanna
Aditx
Therapeutics, Inc.
Chief
Executive Officer
2569
Wyandotte Street
Suite
101
Mountain
View, CA 94043
(650)
870-1200
(Name,
address including zip code, and telephone number, including area code, of agent for service)
With
copies to:
Richard
A. Friedman, Esq.
Sean
F. Reid, Esq.
Taylor
J. Ashton, Esq.
Sheppard,
Mullin, Richter & Hampton LLP
30
Rockefeller Plaza
New
York, NY 10112
Tel: (212) 653-8700
Fax:
(212) 653-8701
Approximate
date of commencement of proposed sale to the public: From time to time, after the effective date of this registration statement.
If
the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check
the following box. ☐
If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following
box. ☒
If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering. ☐
If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If
this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective
upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐
If
this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional
securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large
accelerated filer
|
☐
|
Accelerated filer
|
☐
|
Non-accelerated filer
|
☒
|
Smaller reporting company
|
☒
|
|
Emerging growth company
|
☒
|
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of Securities Act. ☐
The
Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the
Registrant shall file a further amendment that specifically states that this Registration Statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act or until this Registration Statement shall become effective on such date as the
Commission, acting pursuant to said Section 8(a), may determine.
EXPLANATORY
NOTE
This Pre-Effective Amendment No. 1 to the Registration
Statement on Form S-3 (File No. 333-257645) is being filed solely for the purpose of including the delaying amendment language set forth
on the cover page hereto. This Pre-Effective Amendment No. 1 does not modify any provision of the prospectus that forms a part of the
registration statement and, accordingly, such prospectus has not been included herein. This Pre-Effective Amendment No. 1 is not intended
to amend or delete any part of the registration statement except as specifically noted herein.
PART II
INFORMATION
NOT REQUIRED IN PROSPECTUS
Item
14. Other Expenses of Issuance and Distribution.
The
following table sets forth an estimate of the fees and expenses relating to the issuance and distribution of the securities being registered
hereby, other than underwriting discounts and commissions, all of which shall be borne by the Company. All of such fees and expenses,
except for the SEC registration fee and the FINRA filing fee, are estimated:
SEC registration fee
|
|
$
|
10,910
|
|
FINRA filing fees
|
|
|
15,500
|
|
Legal fees and expenses
|
|
|
*
|
|
Printing fees and expenses
|
|
|
*
|
|
Accounting fees and expenses
|
|
|
*
|
|
Miscellaneous fees and expenses
|
|
|
*
|
|
Total
|
|
$
|
26,410*
|
|
*
|
These
fees are calculated based on the securities offered and the number of issuances and accordingly cannot be estimated at this time.
The applicable prospectus supplement will set forth the estimated amount of expenses of any offering of securities.
|
Item
15. Indemnification of Officers and Directors.
Section 102
of the General Corporation Law of the State of Delaware (the “DGCL”) permits a corporation to eliminate the personal liability
of directors of a corporation to the corporation or its stockholders for monetary damages for a breach of fiduciary duty as a director,
except where the director breached his duty of loyalty, failed to act in good faith, engaged in intentional misconduct or knowingly violated
a law, authorized the payment of a dividend or approved a stock repurchase in violation of Delaware corporate law or obtained an improper
personal benefit. Our amended and restated certificate of incorporation provides that no director of the Company shall be personally
liable to it or its stockholders for monetary damages for any breach of fiduciary duty as a director, notwithstanding any provision of
law imposing such liability, except to the extent that the DGCL prohibits the elimination or limitation of liability of directors for
breaches of fiduciary duty.
Section 145
of the DGCL provides that a corporation has the power to indemnify a director, officer, employee, or agent of the corporation, or a person
serving at the request of the corporation for another corporation, partnership, joint venture, trust or other enterprise in related capacities
against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred
by the person in connection with an action, suit or proceeding to which he was or is a party or is threatened to be made a party to any
threatened, ending or completed action, suit or proceeding by reason of such position, if such person acted in good faith and in a manner
he reasonably believed to be in or not opposed to the best interests of the corporation, and, in any criminal action or proceeding, had
no reasonable cause to believe his conduct was unlawful, except that, in the case of actions brought by or in the right of the corporation,
no indemnification shall be made with respect to any claim, issue or matter as to which such person shall have been adjudged to be liable
to the corporation unless and only to the extent that the Court of Chancery or other adjudicating court determines that, despite the
adjudication of liability but in view of all of the circumstances of the case, such person is fairly and reasonably entitled to indemnity
for such expenses which the Court of Chancery or such other court shall deem proper.
Our
Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws provide indemnification for our directors and officers
to the fullest extent permitted by the DGCL. We will indemnify each person who was or is a party or threatened to be made a party to
any threatened, pending or completed action, suit or proceeding (other than an action by or in the right of us) by reason of the fact
that he or she is or was, or has agreed to become, a director or officer, or is or was serving, or has agreed to serve, at our request
as a director, officer, partner, employee or trustee of, or in a similar capacity with, another corporation, partnership, joint venture,
trust or other enterprise (all such persons being referred to as an “Indemnitee”), or by reason of any action alleged to
have been taken or omitted in such capacity, against all expenses (including attorneys’ fees), judgments, fines and amounts paid
in settlement actually and reasonably incurred in connection with such action, suit or proceeding and any appeal therefrom, if such Indemnitee
acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, our best interests, and, with respect
to any criminal action or proceeding, he or she had no reasonable cause to believe his or her conduct was unlawful. Our Amended and Restated
Certificate of Incorporation and Amended and Restated Bylaws provide that we will indemnify any Indemnitee who was or is a party to an
action or suit by or in the right of us to procure a judgment in our favor by reason of the fact that the Indemnitee is or was, or has
agreed to become, a director or officer, or is or was serving, or has agreed to serve, at our request as a director, officer, partner,
employee or trustee of, or in a similar capacity with, another corporation, partnership, joint venture, trust or other enterprise, or
by reason of any action alleged to have been taken or omitted in such capacity, against all expenses (including attorneys’ fees)
and, to the extent permitted by law, amounts paid in settlement actually and reasonably incurred in connection with such action, suit
or proceeding, and any appeal therefrom, if the Indemnitee acted in good faith and in a manner he or she reasonably believed to be in,
or not opposed to, our best interests, except that no indemnification shall be made with respect to any claim, issue or matter as to
which such person shall have been adjudged to be liable to us, unless a court determines that, despite such adjudication but in view
of all of the circumstances, he or she is entitled to indemnification of such expenses. Notwithstanding the foregoing, to the extent
that any Indemnitee has been successful, on the merits or otherwise, he or she will be indemnified by us against all expenses (including
attorneys’ fees) actually and reasonably incurred in connection therewith. Expenses must be advanced to an Indemnitee under certain
circumstances.
We
intend to enter into separate indemnification agreements with each of our directors and executive officers. Each indemnification agreement
will provide, among other things, for indemnification to the fullest extent permitted by law and our Amended and Restated Certificate
of Incorporation and Amended and Restated Bylaws against any and all expenses, judgments, fines, penalties and amounts paid in settlement
of any claim. The indemnification agreements will provide for the advancement or payment of all expenses to the indemnitee and for the
reimbursement to us if it is found that such indemnitee is not entitled to such indemnification under applicable law and our Amended
and Restated Certificate of Incorporation and Amended and Restated Bylaws.
We
maintain a general liability insurance policy that covers certain liabilities of directors and officers of our corporation arising out
of claims based on acts or omissions in their capacities as directors or officers.
Item
16. Exhibits.
Exhibit
Number
|
|
Description of Document
|
1.1**
|
|
Form of
Underwriting Agreement
|
|
|
|
3.1*
|
|
Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement on S-1, filed with the SEC on June 25, 2020)
|
|
|
|
3.2*
|
|
Certificate of Amendment, dated June 29, 2020 (incorporated by reference to the Company’s Quarterly Report on Form 10-Q, filed with the SEC on August 13, 2020)
|
|
|
|
3.3*
|
|
Certificate of Amendment, dated May 24, 2021 (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the SEC on May 25, 2021)
|
|
|
|
3.4*
|
|
Amended and Restated Bylaws (incorporated by reference to Exhibit 3.3 to the Company’s Registration Statement on Form S-1, filed with the SEC on June 25, 2020)
|
|
|
|
3.5**
|
|
Form
of Certificate of Designation with respect to Preferred Stock
|
|
|
|
4.1*
|
|
Form of Common Stock Certificate (incorporated by reference to Company’s Registration Statement on Form S-1 (File No. 333-248491)
|
|
|
|
4.2*
|
|
Form of Senior Indenture
|
|
|
|
4.3*
|
|
Form of Subordinated Indenture
|
|
|
|
4.4**
|
|
Form of
Senior Note
|
|
|
|
4.5**
|
|
Form of
Subordinated Note
|
|
|
|
4.6**
|
|
Form of
Warrant
|
|
|
|
4.7**
|
|
Form of
Warrant Agreement
|
|
|
|
4.8**
|
|
Form
of Rights Agreement and Rights Certificate
|
|
|
|
4.9**
|
|
Form of
Unit Agreement
|
|
|
|
5.1*
|
|
Opinion of Sheppard, Mullin, Richter & Hampton LLP as to the legality of the securities being registered (incorporated by reference to Exhibit 5.1 to the Registration Statement on Form S-3 (File No. 333-257645), filed on July 2, 2021)
|
|
|
|
23.1*
|
|
Consent of dbbmckennon, Independent Registered Public Accounting Firm (incorporated by reference to Exhibit 23.1 to the Registration Statement on Form S-3 (File No. 333-257645), filed on July 2, 2021)
|
|
|
|
23.2*
|
|
Consent of Sheppard, Mullin, Richter & Hampton LLP (included in Exhibit 5.1)
|
|
|
|
24.1*
|
|
Power of Attorney (included on signature page to the registration statement)
|
|
|
|
25.1**
|
|
Statement
of Eligibility of Trustee on Form T-1 under the Trust Indenture Act of 1939, as amended
|
**
|
To
the extent applicable, to be filed by an amendment or as an exhibit to a document filed under the Securities Exchange Act of 1934,
as amended, and incorporated by reference herein.
|
Item
17. Undertakings.
(a)
The undersigned registrant hereby undertakes:
(1)
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
(i)
To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;
(ii)
To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration
statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities
offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range
may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes
in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the “Calculation
of Registration Fee” table in the effective registration statement; and
(iii)
To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or
any material change to such information in the registration statement;
provided,
however, that paragraphs (a)(1)(i), (a)(1)(ii), and (a)(1)(iii) above do not apply if the information required to be included
in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant
pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the
registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is a part of the registration
statement.
(2) That,
for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to
be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be
deemed to be the initial bona fide offering thereof.
(3) To
remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination
of the offering.
(5) That,
for the purpose of determining liability under the Securities Act of 1933 to any purchaser:
(A) Each
prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of
the date the filed prospectus was deemed part of and included in the registration statement; and
(B) Each
prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance
on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the
information required by Section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration
statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of
sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any
person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating
to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall
be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement
or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into
the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of
sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was
part of the registration statement or made in any such document immediately prior to such effective date.
(6) That,
for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution
of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant
to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities
are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to
the purchaser and will be considered to offer or sell such securities to such purchaser:
(i) Any
preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;
(ii) Any
free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the
undersigned registrant;
(iii) The
portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant
or its securities provided by or on behalf of the undersigned registrant; and
(iv) Any
other communication that is an offer in the offering made by the undersigned registrant to the purchaser.
(b)
The undersigned registrant hereby undertakes to file an application for the purpose of determining the eligibility of the trustee to
act under subsection (a) of Section 310 of the Trust Indenture Act in accordance with the rules and regulations prescribed
by the Commission under Section 305(b)(2) of the Trust Indenture Act.
(c) The
undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing
of the registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act
of 1934 (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of
the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof.
(d) Insofar
as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons
of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities
and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.
In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred
or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is
asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless
in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.
SIGNATURES
Pursuant
to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-3 and has duly caused this Pre-Effective Amendment No. 1 to the Registration Statement
on Form S-3 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Mountain View, State of California,
on July 6, 2021.
|
ADITX
THERAPEUTICS, INC.
|
|
|
|
|
By:
|
/s/
Amro Albanna
|
|
|
Amro
Albanna
|
|
|
Chief
Executive Officer
|
Pursuant to the requirements
of the Securities Act of 1933, the following persons in the capacities and on the dates indicated have signed this Pre-Effective Amendment
No. 1 to the Registration Statement on Form S-3 below.
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
/s/
Amro Albanna
|
|
Chief
Executive Officer, President and Director
|
|
July
6, 2021
|
Amro
Albanna
|
|
(Principal
Executive Officer)
|
|
|
|
|
|
|
|
*
|
|
Chief
Financial Officer
|
|
July
6, 2021
|
Corinne
Pankovcin
|
|
(Principal
Financial Officer)
|
|
|
|
|
|
|
|
*
|
|
Controller
|
|
July
6, 2021
|
Thomas
J. Farley
|
|
(Principal
Accounting Officer)
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
July
6, 2021
|
Laura
E. Anthony
|
|
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
July
6, 2021
|
Lauren
Chung
|
|
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
July
6, 2021
|
Brian
Brady
|
|
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
July
6, 2021
|
Namvar
Kiaie
|
|
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
July
6, 2021
|
Jeffrey
W. Runge, M.D.
|
|
|
|
|
|
|
|
|
|
*
|
|
Chief
Innovation Officer and Director
|
|
July
6, 2021
|
Shahrokh
Shabahang
|
|
|
|
|
|
|
|
|
|
*By:
|
/s/
Amro Albanna
|
|
|
|
|
|
Amro
Albanna
Attorney-in-Fact
|
|
|
|
|
II-5
Aditxt (NASDAQ:ADTX)
Historical Stock Chart
From May 2024 to Jun 2024
Aditxt (NASDAQ:ADTX)
Historical Stock Chart
From Jun 2023 to Jun 2024